Agios Pharmaceuticals Inc (NASDAQ: AGIO) stock closed at $51.59 on 11/6/24 after a major increase of 10.5%. Moreover, this advance was accompanied by exceptionally high trading volume at 229% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 10.2% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, AGIO is expected to be a modest Value Builder.
Agios Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Agios Pharmaceuticals has a very low Appreciation Score of 14 but a good Power Rating of 83, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment